Orbel Health completes £250,000 investment round
Funding to fuel development of groundbreaking hand gel dispenser
London-based start-up Orbel Health Ltd has received £250,000 in funding for the development of its groundbreaking hand gel dispenser.
The investment, provided by a London Business Angel (LBA) syndicate, will enable Orbel to further tweak its alcohol-based dispenser, begin active trials and explore a raft of B2B applications in the international healthcare sector. Designed to arrest the spread of hospital-acquired infections such as MRSA, the dispenser has already been endorsed by the National Patient Safety Agency and received enquiries from a multinational B2C company. Adam Sutcliffe, founder of Orbel Health and inventor of the product, said LBA has already provided a wealth of expertise, as well as money, to help his fledgling company. “Apart from being exceptionally fruitful, the whole process of working with LBA, and the guidance they have provided, has been excellent. “The future for Orbel is exceptionally bright and I hope that our involvement, and success, with LBA will encourage more Design London incubees to seek their help in gaining second round support.” Anthony Clarke, managing Director of LBA, added that his body “is delighted to have helped Adam and Orbel Healthcare to close this significant seed round which will allow the business to take its unique product to market.”